Hematology Oncology Consultants

Quick facts

Phase 2 pipeline

• Doxil and Vinorelbine · Oncology
  Docetaxel, a microtubule inhibitor, binds to tubulin and prevents microtubule assembly, thereby inhibiting cell division.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Hematology Oncology Consultants portfolio CI brief
• Hematology Oncology Consultants pipeline updates RSS